Enyo Pharma, a Lyon-based biotech, raises €40M in a Series B round from OrbiMed, Andera Partners and Bpifrance to fund two Phase II clinical trials.
Raised from
Undisclosed
11 / 2024
Menu
Enyo Pharma, a Lyon-based biotech, raises €40M in a Series B round from OrbiMed, Andera Partners and Bpifrance to fund two Phase II clinical trials.
